Use of Topical Corticosteroids in the Treatment of Noninfectious Inflammatory Dermatoses of the Scalp: A Survey of Practicing Dermatologists and Dermatology Residents Using Delphi Methodology

References

• Grimalt R. A practical guide to scalp disorders. J Investig Dermatol Symp Proc. 2007;12(2):10–14. doi:10.1038/sj.jidsymp.5650048
   PubMedGoogle Scholar
• van de Kerkhof PC, Franssen ME. Psoriasis of the scalp. Diagnosis and management. Am J Clin Dermatol. 2001;2(3):159–165. doi:10.2165/00128071-200102030-00005
   PubMedGoogle Scholar
• Mosca M, Hong J, Hadeler E, Brownstone N, Bhutani T, Liao W. Scalp psoriasis: a literature review of effective therapies and updated recommendations for practical management. Dermatol Ther. 2021;11(3):769–797. doi:10.1007/s13555-021-00521-z
   PubMed Web of Science ®Google Scholar
• Lee S, Lee WS. Management of alopecia areata: updates and algorithmic approach. J Dermatol. 2017;44(11):1199–1211. doi:10.1111/1346-8138.13933
   PubMed Web of Science ®Google Scholar
• Gooderham M, Blakely K. Management of scalp psoriasis: current perspectives. Psoriasis. 2016;33. doi:10.2147/PTT.S85330
   PubMedGoogle Scholar
• Nair AB, Kumar S, Dalal P, et al. Novel dermal delivery cargos of clobetasol propionate: an update. Pharmaceutics. 2022;14(2). doi:10.3390/pharmaceutics14020383
   Web of Science ®Google Scholar
• Olsen EA, Cram DL, Ellis CN, et al. A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis. J Am Acad Dermatol. 1991;24(3):443–447.
   PubMed Web of Science ®Google Scholar
• Sidbury R, Alikhan A, Bercovitch L, et al. Guidelines of care for the management of atopic dermatitis in adults with topical therapies. J Am Acad Dermatol. 2023;89(1):128–129. doi:10.1016/j.jaad.2022.08.068
   PubMed Web of Science ®Google Scholar
• Barrett D, Heale R. What are delphi studies? Evidence Based Nurs. 2020;23(3):68–69. doi:10.1136/ebnurs-2020-103303
   PubMedGoogle Scholar
• Eysenbach G. Improving the quality of web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34. doi:10.2196/jmir.6.3.e34
   PubMed Web of Science ®Google Scholar
• Chan CS, Van Voorhees AS, Lebwohl MG, et al. Treatment of severe scalp psoriasis: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009;60(6):962–971. doi:10.1016/j.jaad.2008.11.890
   PubMed Web of Science ®Google Scholar
• Mason A, Mason J, Cork M, Hancock H, Dooley G. Topical treatments for chronic plaque psoriasis: an abridged Cochrane systematic review. J Am Acad Dermatol. 2013;69(5):799–807. doi:10.1016/j.jaad.2013.06.027
   PubMed Web of Science ®Google Scholar
• Schlager JG, Rosumeck S, Werner RN, et al. Topical treatments for scalp psoriasis. Cochrane Database Syst Rev. 2016;2(2):Cd009687. doi:10.1002/14651858.CD009687.pub2
   PubMedGoogle Scholar
• Ortonne J, Chimenti S, Luger T, Puig L, Reid F, Trüeb R. Scalp psoriasis: European consensus on grading and treatment algorithm. J Eur Acad Dermatol Venereol. 2009;23(12):1435–1444. doi:10.1111/j.1468-3083.2009.03372.x
   PubMed Web of Science ®Google Scholar
• Company-Quiroga J, Alique-García S, Romero-Maté A. Current insights into the management of discoid lupus erythematosus. Clin Cosmet Invest Dermatol. 2019;12:721–732. doi:10.2147/CCID.S184824
   PubMed Web of Science ®Google Scholar
• Ioannides D, Vakirlis E, Kemeny L, et al. European S1 guidelines on the management of lichen planus: a cooperation of the European Dermatology Forum with the European Academy of Dermatology and Venereology. J Eur Acad Dermatol Venereol. 2020;34(7):1403–1414. doi:10.1111/jdv.16464
   PubMed Web of Science ®Google Scholar
• Ucak H, Kandi B, Cicek D, Halisdemir N, Dertlıoğlu SB. The comparison of treatment with clobetasol propionate 0.05% and topical pimecrolimus 1% treatment in the treatment of alopecia areata. J Dermatol Treat. 2012;23(6):410–420. doi:10.3109/09546634.2011.590788
   PubMed Web of Science ®Google Scholar
• Hald M, Arendrup MC, Svejgaard EL, Lindskov R, Foged EK, Saunte DM. Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases. Acta Derm Venereol. 2015;95(1):12–19. doi:10.2340/00015555-1825
   PubMed Web of Science ®Google Scholar
• Juarez MC, Kwatra SG. A systematic review of evidence based treatments for lichen simplex chronicus. J Dermatological Treat. 2021;32(7):684–692. doi:10.1080/09546634.2019.1708856
   PubMed Web of Science ®Google Scholar
• van de Kerkhof PC, de Hoop D, de Korte J, Cobelens SA, Kuipers MV. Patient compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology. 2000;200(4):292–298. doi:10.1159/000018390
   PubMed Web of Science ®Google Scholar
• Lassus A. Local treatment of psoriasis of the scalp with clobetasol propionate in alcoholic solution: a comparison of once and twice a day application. Curr Med Res Opin. 1976;4(3):214–217. doi:10.1185/03007997609109306
   PubMedGoogle Scholar
• Bergstrom KG, Arambula K, Kimball AB. Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis. Cutis. 2003;72(5):407–411.
   PubMed Web of Science ®Google Scholar
• Poulin Y, Papp K, Bissonnette R, Barber K, Kerrouche N, Villemagne H. Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis. J Dermatol Treat. 2010;21(3):185–192. doi:10.3109/09546630903493311
   PubMed Web of Science ®Google Scholar
• Dubertret L, Mrowietz U, Ranki A, et al. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol. 2006;155(4):729–736. doi:10.1111/j.1365-2133.2006.07405.x
   PubMed Web of Science ®Google Scholar
• Katz HI, Lindholm JS, Weiss JS, et al. Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis. Clin Ther. 1995;17(3):390–401. doi:10.1016/0149-2918(95)80104-9
   PubMed Web of Science ®Google Scholar
• Lebwohl MG, Bachelez H, Barker J, et al. Patient perspectives in the management of psoriasis: results from the population-based multinational assessment of psoriasis and psoriatic arthritis survey. J Am Acad Dermatol. 2014;70(5):871–81.e1-30. doi:10.1016/j.jaad.2013.12.018
   Web of Science ®Google Scholar
• Heydendael VM, de Borgie CA, Spuls PI, Bossuyt PM, Bos JD, de Rie MA. The burden of psoriasis is not determined by disease severity only. J Investig Dermatol Symp Proc. 2004;9(2):131–135. doi:10.1111/j.1087-0024.2004.09115.x
   PubMedGoogle Scholar
• Norman Dalkey OH, Helmer O. An experimental application of the DELPHI method to the use of experts. Manage Sci. 1963;9(3):458–467. doi:10.1287/mnsc.9.3.458
   Web of Science ®Google Scholar